Epcoritamab for treating relapsed or refractory follicular lymphoma after 2 or more lines of systemic treatment TA1139 11 March 2026 11 March 2026 Durvalumab with gemcitabine and cisplatin for ...

Domvanalimab with zimberelimab for untreated unresectable advanced gastric, gastro-oesophageal junction or oesophageal cancer [ID6606] Technology appraisal guidance TBC Donanemab for treating mild ...

WIRED is obsessed with what comes next. Through rigorous investigations and game-changing reporting, we tell stories that don’t just reflect the moment—they help create it. When you look back in 10, ...